EuBiologics Co., Ltd. (206650.KQ)
KRW 11700.0
(0.0%)
KRW 11700.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 69.36 Billion KRW | 25.06% |
| 2022 | 55.46 Billion KRW | 40.83% |
| 2021 | 39.38 Billion KRW | 38.24% |
| 2020 | 28.48 Billion KRW | -13.86% |
| 2019 | 33.07 Billion KRW | 32.86% |
| 2018 | 24.89 Billion KRW | 115.18% |
| 2017 | 11.56 Billion KRW | 138.76% |
| 2016 | 4.84 Billion KRW | 202.3% |
| 2015 | 1.6 Billion KRW | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 15.18 Billion KRW | -43.52% |
| 2024 Q2 | 7.86 Billion KRW | -48.21% |
| 2023 Q3 | 11.43 Billion KRW | -31.32% |
| 2023 Q2 | 16.64 Billion KRW | 15.64% |
| 2023 FY | 69.36 Billion KRW | 25.06% |
| 2023 Q1 | 14.39 Billion KRW | -17.37% |
| 2023 Q4 | 26.89 Billion KRW | 135.23% |
| 2022 Q1 | 10.72 Billion KRW | -13.71% |
| 2022 FY | 55.46 Billion KRW | 40.83% |
| 2022 Q3 | 12.76 Billion KRW | -12.36% |
| 2022 Q2 | 14.56 Billion KRW | 35.83% |
| 2022 Q4 | 17.41 Billion KRW | 36.49% |
| 2021 Q3 | 10.82 Billion KRW | 22.45% |
| 2021 Q1 | 7.29 Billion KRW | 0.0% |
| 2021 FY | 39.38 Billion KRW | 38.24% |
| 2021 Q2 | 8.83 Billion KRW | 21.15% |
| 2021 Q4 | 12.42 Billion KRW | 14.8% |
| 2020 FY | 28.48 Billion KRW | -13.86% |
| 2019 FY | 33.07 Billion KRW | 32.86% |
| 2018 FY | 24.89 Billion KRW | 115.18% |
| 2017 FY | 11.56 Billion KRW | 138.76% |
| 2016 FY | 4.84 Billion KRW | 202.3% |
| 2015 FY | 1.6 Billion KRW | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 135.95 Billion KRW | 48.978% |
| CMG Pharmaceutical Co., Ltd. | 93.9 Billion KRW | 26.133% |
| Celltrion Pharm, Inc. | 388.79 Billion KRW | 82.159% |
| Huons Global Co., Ltd. | 758.37 Billion KRW | 90.853% |
| DongKook Pharmaceutical Co., Ltd. | 730.99 Billion KRW | 90.511% |
| Enzychem Lifesciences Corporation | 76.03 Billion KRW | 8.776% |
| Humedix Co., Ltd. | 152.27 Billion KRW | 54.447% |
| Boditech Med Inc. | 134.21 Billion KRW | 48.319% |
| FutureChem Co.,Ltd | 13.96 Billion KRW | -396.604% |
| Huons Co., Ltd. | 552 Billion KRW | 87.434% |
| BNC Korea Co., Ltd. | 80.99 Billion KRW | 14.361% |
| AptaBio Therapeutics Inc. | 323.86 Million KRW | -21317.826% |